Acceldata is named a Pace Setter in the Gartner® Emerging Market Quadrant for AI FinOps Tools - Startup Vendors.
Al agents turn one request into dozens of model, tool and API calls, and the bill arrives weeks later. We believe Gartner® maps the tools built to measure, attribute and control that spend. Get your complimentary copy.
We believe AI bills don’t come with a forecast, and that the monthly report arrives too late to change what was spent.
"An after-the-fact monthly report is insufficient to prevent inefficient AI spend."
Gartner®, Emerging Market Quadrant for AI FinOps Tools - Startup Vendors, Ray Collins, Adam Ronthal, Marco Meinardi, Nitish Tyagi, 28 October 2026
“Measuring AI spend in isolation answers ‘What did we spend?’ but not ‘Was it worth it?’”
Source: Gartner®, Emerging Market Quadrant for AI FinOps Tools - Startup Vendors, Ray Collins, Adam Ronthal, Marco Meinardi, Nitish Tyagi, 28 October 2026.

This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from https://go.acceldata.io/gartner-ai-finops-emerging-market-quadrant.
The token bill is the one everyone watches. The bill underneath it is the data your AI runs on: platforms, pipelines and copies that keep growing every year. We believe that's where the money for AI is locked up. Fund production AI from today's estate, and keep your data where it is.
Thirty minutes. We'll talk through where your AI budget is locked up.
Talk to an ExpertGARTNER is a trademark of Gartner, Inc. and/or its affiliates.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.